• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD FEMORAL HEAD 44MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD FEMORAL HEAD 44MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74123144
Device Problem Biocompatibility (2886)
Patient Problem Metal Related Pathology (4530)
Event Date 01/10/2022
Event Type  Injury  
Event Description
Bilateral patient.It was reported that, after a bilateral bhr resurfacing construct had been implanted on the patient¿s left and right hip on (b)(6) 2009 respectively, the patient required a revision arthroplasty of the right hip implants on (b)(6) 2022.Among the reported symptoms that made necessary this intervention, the patient experienced elevated cobalt levels in blood referred as to be ¿in the upper 40's¿.Although there is no evidence of any intervention performed on the left bhr resurfacing implants, the contribution of this prosthesis to the reported cobalt levels could not be discarded.
 
Manufacturer Narrative
Internal complaint reference: (b)(4).
 
Manufacturer Narrative
H3, h6: it was reported that after a bhr resurfacing construct had been implanted on the patient¿s left hip, the patient experienced elevated cobalt levels in blood.There is no evidence of any intervention performed on the left bhr resurfacing implants, but the patient underwent revision surgery for the right hip.As of today, the implanted devices, all of which were used in treatment are not accessible for intervention.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the acetabular cup and similar complaints have been identified for the femoral head.However, as the devices are no longer sold, no action is to be taken.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.Although elevated cobalt was reported, no units of measure nor lab reports were provided.With the limited information provided the clinical root cause of the reported elevated cobalt cannot be confirmed.It cannot be concluded the elevated cobalt was associated with a malperformance of the implant or implant failure.No revision has been reported.Based on the information provided we cannot confirm or further investigate the reported complaint, our investigation remains inconclusive, and a definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMORAL HEAD 44MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK  CV31 3HL
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house, spa park
leamington spa warwickshire CV31 3HL
UK   CV31 3HL
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key14844913
MDR Text Key295061337
Report Number3005975929-2022-00409
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010552419
UDI-Public3596010552419
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2011
Device Catalogue Number74123144
Device Lot Number9710
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 06/08/2022
Initial Date FDA Received06/28/2022
Supplement Dates Manufacturer Received09/13/2022
Supplement Dates FDA Received09/14/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2267-2018 & Z-2268-201
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age51 YR
Patient SexFemale
-
-